Advanced Science-期刊论坛，投稿经验-MedSci.cn

[GetPortalCommentsPageByObjectIdResponse(id=1223591, encodeId=308412235916f, content=偏重的研究方向：生命科学;生命科学医药学 经验分享：这个杂志真的慢生命科学方向的着急一定要慎投投过去了 Manuscript Submitted持续了12天了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9bf5125548, createdName=146453fam52暂无昵称, createdTime=Tue May 31 13:38:07 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230893, encodeId=e1c91230893ca, content=偏重的研究方向：医学;生命科学 经验分享：6.7号送审，under review，一个月了还没消息，医学类一般几个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabc8228192, createdName=ms8000002010566297, createdTime=Wed Jul 06 12:18:42 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154655, encodeId=31112154655d3, content=偏重的研究方向：医学;神经免疫 经验分享：大家最近投这个的进度怎么样呀？我们最近投的一篇2周了还在manuscript submitted，很着急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19c03114550, createdName=Ozeaaan, createdTime=Sat Aug 26 08:39:27 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156715, encodeId=1bc32156e15fd, content=偏重的研究方向：医学;分子生物学 经验分享：请问under review 后多久有审稿意见回来？被拒稿的概率大吗？投稿小CDD被拒了，转投这个，送审了……担心😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Fri Sep 08 15:23:25 CST 2023, time=2023-09-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1221757, encodeId=619e1221e57aa, content=请问一下:Submitted状态5天了，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Mon May 23 14:40:15 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166784, encodeId=54962166e8461, content=偏重的研究方向：神经内分泌;肠道菌群 经验分享：大家都是with editor 多久送审的?我这边with editor一周了，加上之前的submitted，前后加起来已经两周了，等的捉急，着急毕业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb55107687, createdName=悲伤的猪大肠, createdTime=Sun Nov 05 11:37:18 CST 2023, time=2023-11-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2165098, encodeId=5c24216509831, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基础医学 经验分享：第一次投稿15+的综合期刊，期间各种焦虑不安，好在虽然波折但是总体顺利。审稿人都很友好，对于完善文章逻辑、优化结果展示都提出了很多有用的建议，也一一遵照修改了。 贡献一波时间线，再次祝大家投稿顺利，成果多多！ 7-26 Submit 8-15 With Editor 8-16 Under Review 9-13 Major Revision 10-2 Resubmit 10-4 Under Review 10-22 Required Reviews Completed 10-25 Accept with no change, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231105/78c8e721cf4145ccb144631f19378e1f/f8edb1c66f194d06b01e9cc8bb05e117.jpg, createdBy=32d65269159, createdName=Getting accept, createdTime=Thu Oct 26 21:06:03 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息？已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2119953, encodeId=9f66211995360, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：医学基础 经验分享：分享一下投稿经历 11-29 submit 11-26 with editor 11-29 under review 12-21 major review 2-8 re-submit后直接under review 3-10 accept 比较流畅的投稿经历，不过也经历了国自然截止期二审时间长于一审的焦虑，好在最后都赶上了。希望大家都投稿顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f41700843, createdName=1de7ee0bm45(暂无匿称), createdTime=Thu Mar 16 13:33:35 CST 2023, time=2023-03-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1232439, encodeId=de1c123243921, content=二审马上一个月了审稿人也没提多少问题啊等到心梗了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89295434420, createdName=ms7000000746658693, createdTime=Thu Jul 14 15:24:20 CST 2022, time=2022-07-14, status=1, ipAttribution=)]

2022-05-31 146453fam52暂无昵称

偏重的研究方向：生命科学;生命科学医药学
经验分享：这个杂志真的慢生命科学方向的着急一定要慎投投过去了 Manuscript Submitted持续了12天了还没有消息

103 23

展开23条回复

[GetPortalCommentsPageByObjectIdResponse(id=1223591, encodeId=308412235916f, content=偏重的研究方向：生命科学;生命科学医药学 经验分享：这个杂志真的慢生命科学方向的着急一定要慎投投过去了 Manuscript Submitted持续了12天了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9bf5125548, createdName=146453fam52暂无昵称, createdTime=Tue May 31 13:38:07 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230893, encodeId=e1c91230893ca, content=偏重的研究方向：医学;生命科学 经验分享：6.7号送审，under review，一个月了还没消息，医学类一般几个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabc8228192, createdName=ms8000002010566297, createdTime=Wed Jul 06 12:18:42 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154655, encodeId=31112154655d3, content=偏重的研究方向：医学;神经免疫 经验分享：大家最近投这个的进度怎么样呀？我们最近投的一篇2周了还在manuscript submitted，很着急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19c03114550, createdName=Ozeaaan, createdTime=Sat Aug 26 08:39:27 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156715, encodeId=1bc32156e15fd, content=偏重的研究方向：医学;分子生物学 经验分享：请问under review 后多久有审稿意见回来？被拒稿的概率大吗？投稿小CDD被拒了，转投这个，送审了……担心😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Fri Sep 08 15:23:25 CST 2023, time=2023-09-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1221757, encodeId=619e1221e57aa, content=请问一下:Submitted状态5天了，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Mon May 23 14:40:15 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166784, encodeId=54962166e8461, content=偏重的研究方向：神经内分泌;肠道菌群 经验分享：大家都是with editor 多久送审的?我这边with editor一周了，加上之前的submitted，前后加起来已经两周了，等的捉急，着急毕业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb55107687, createdName=悲伤的猪大肠, createdTime=Sun Nov 05 11:37:18 CST 2023, time=2023-11-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2165098, encodeId=5c24216509831, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基础医学 经验分享：第一次投稿15+的综合期刊，期间各种焦虑不安，好在虽然波折但是总体顺利。审稿人都很友好，对于完善文章逻辑、优化结果展示都提出了很多有用的建议，也一一遵照修改了。 贡献一波时间线，再次祝大家投稿顺利，成果多多！ 7-26 Submit 8-15 With Editor 8-16 Under Review 9-13 Major Revision 10-2 Resubmit 10-4 Under Review 10-22 Required Reviews Completed 10-25 Accept with no change, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231105/78c8e721cf4145ccb144631f19378e1f/f8edb1c66f194d06b01e9cc8bb05e117.jpg, createdBy=32d65269159, createdName=Getting accept, createdTime=Thu Oct 26 21:06:03 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息？已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2119953, encodeId=9f66211995360, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：医学基础 经验分享：分享一下投稿经历 11-29 submit 11-26 with editor 11-29 under review 12-21 major review 2-8 re-submit后直接under review 3-10 accept 比较流畅的投稿经历，不过也经历了国自然截止期二审时间长于一审的焦虑，好在最后都赶上了。希望大家都投稿顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f41700843, createdName=1de7ee0bm45(暂无匿称), createdTime=Thu Mar 16 13:33:35 CST 2023, time=2023-03-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1232439, encodeId=de1c123243921, content=二审马上一个月了审稿人也没提多少问题啊等到心梗了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89295434420, createdName=ms7000000746658693, createdTime=Thu Jul 14 15:24:20 CST 2022, time=2022-07-14, status=1, ipAttribution=)]

2022-07-06 ms8000002010566297

偏重的研究方向：医学;生命科学
经验分享：6.7号送审，under review，一个月了还没消息，医学类一般几个审稿人？

79 23

展开23条回复

[GetPortalCommentsPageByObjectIdResponse(id=1223591, encodeId=308412235916f, content=偏重的研究方向：生命科学;生命科学医药学 经验分享：这个杂志真的慢生命科学方向的着急一定要慎投投过去了 Manuscript Submitted持续了12天了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9bf5125548, createdName=146453fam52暂无昵称, createdTime=Tue May 31 13:38:07 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230893, encodeId=e1c91230893ca, content=偏重的研究方向：医学;生命科学 经验分享：6.7号送审，under review，一个月了还没消息，医学类一般几个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabc8228192, createdName=ms8000002010566297, createdTime=Wed Jul 06 12:18:42 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154655, encodeId=31112154655d3, content=偏重的研究方向：医学;神经免疫 经验分享：大家最近投这个的进度怎么样呀？我们最近投的一篇2周了还在manuscript submitted，很着急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19c03114550, createdName=Ozeaaan, createdTime=Sat Aug 26 08:39:27 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156715, encodeId=1bc32156e15fd, content=偏重的研究方向：医学;分子生物学 经验分享：请问under review 后多久有审稿意见回来？被拒稿的概率大吗？投稿小CDD被拒了，转投这个，送审了……担心😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Fri Sep 08 15:23:25 CST 2023, time=2023-09-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1221757, encodeId=619e1221e57aa, content=请问一下:Submitted状态5天了，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Mon May 23 14:40:15 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166784, encodeId=54962166e8461, content=偏重的研究方向：神经内分泌;肠道菌群 经验分享：大家都是with editor 多久送审的?我这边with editor一周了，加上之前的submitted，前后加起来已经两周了，等的捉急，着急毕业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb55107687, createdName=悲伤的猪大肠, createdTime=Sun Nov 05 11:37:18 CST 2023, time=2023-11-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2165098, encodeId=5c24216509831, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基础医学 经验分享：第一次投稿15+的综合期刊，期间各种焦虑不安，好在虽然波折但是总体顺利。审稿人都很友好，对于完善文章逻辑、优化结果展示都提出了很多有用的建议，也一一遵照修改了。 贡献一波时间线，再次祝大家投稿顺利，成果多多！ 7-26 Submit 8-15 With Editor 8-16 Under Review 9-13 Major Revision 10-2 Resubmit 10-4 Under Review 10-22 Required Reviews Completed 10-25 Accept with no change, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231105/78c8e721cf4145ccb144631f19378e1f/f8edb1c66f194d06b01e9cc8bb05e117.jpg, createdBy=32d65269159, createdName=Getting accept, createdTime=Thu Oct 26 21:06:03 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息？已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2119953, encodeId=9f66211995360, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：医学基础 经验分享：分享一下投稿经历 11-29 submit 11-26 with editor 11-29 under review 12-21 major review 2-8 re-submit后直接under review 3-10 accept 比较流畅的投稿经历，不过也经历了国自然截止期二审时间长于一审的焦虑，好在最后都赶上了。希望大家都投稿顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f41700843, createdName=1de7ee0bm45(暂无匿称), createdTime=Thu Mar 16 13:33:35 CST 2023, time=2023-03-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1232439, encodeId=de1c123243921, content=二审马上一个月了审稿人也没提多少问题啊等到心梗了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89295434420, createdName=ms7000000746658693, createdTime=Thu Jul 14 15:24:20 CST 2022, time=2022-07-14, status=1, ipAttribution=)]

2023-08-26 Ozeaaan 来自江苏省

偏重的研究方向：医学;神经免疫
经验分享：大家最近投这个的进度怎么样呀？我们最近投的一篇2周了还在manuscript submitted，很着急。。。

247 19

展开19条回复

[GetPortalCommentsPageByObjectIdResponse(id=1223591, encodeId=308412235916f, content=偏重的研究方向：生命科学;生命科学医药学 经验分享：这个杂志真的慢生命科学方向的着急一定要慎投投过去了 Manuscript Submitted持续了12天了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9bf5125548, createdName=146453fam52暂无昵称, createdTime=Tue May 31 13:38:07 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230893, encodeId=e1c91230893ca, content=偏重的研究方向：医学;生命科学 经验分享：6.7号送审，under review，一个月了还没消息，医学类一般几个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabc8228192, createdName=ms8000002010566297, createdTime=Wed Jul 06 12:18:42 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154655, encodeId=31112154655d3, content=偏重的研究方向：医学;神经免疫 经验分享：大家最近投这个的进度怎么样呀？我们最近投的一篇2周了还在manuscript submitted，很着急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19c03114550, createdName=Ozeaaan, createdTime=Sat Aug 26 08:39:27 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156715, encodeId=1bc32156e15fd, content=偏重的研究方向：医学;分子生物学 经验分享：请问under review 后多久有审稿意见回来？被拒稿的概率大吗？投稿小CDD被拒了，转投这个，送审了……担心😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Fri Sep 08 15:23:25 CST 2023, time=2023-09-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1221757, encodeId=619e1221e57aa, content=请问一下:Submitted状态5天了，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Mon May 23 14:40:15 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166784, encodeId=54962166e8461, content=偏重的研究方向：神经内分泌;肠道菌群 经验分享：大家都是with editor 多久送审的?我这边with editor一周了，加上之前的submitted，前后加起来已经两周了，等的捉急，着急毕业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb55107687, createdName=悲伤的猪大肠, createdTime=Sun Nov 05 11:37:18 CST 2023, time=2023-11-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2165098, encodeId=5c24216509831, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基础医学 经验分享：第一次投稿15+的综合期刊，期间各种焦虑不安，好在虽然波折但是总体顺利。审稿人都很友好，对于完善文章逻辑、优化结果展示都提出了很多有用的建议，也一一遵照修改了。 贡献一波时间线，再次祝大家投稿顺利，成果多多！ 7-26 Submit 8-15 With Editor 8-16 Under Review 9-13 Major Revision 10-2 Resubmit 10-4 Under Review 10-22 Required Reviews Completed 10-25 Accept with no change, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231105/78c8e721cf4145ccb144631f19378e1f/f8edb1c66f194d06b01e9cc8bb05e117.jpg, createdBy=32d65269159, createdName=Getting accept, createdTime=Thu Oct 26 21:06:03 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息？已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2119953, encodeId=9f66211995360, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：医学基础 经验分享：分享一下投稿经历 11-29 submit 11-26 with editor 11-29 under review 12-21 major review 2-8 re-submit后直接under review 3-10 accept 比较流畅的投稿经历，不过也经历了国自然截止期二审时间长于一审的焦虑，好在最后都赶上了。希望大家都投稿顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f41700843, createdName=1de7ee0bm45(暂无匿称), createdTime=Thu Mar 16 13:33:35 CST 2023, time=2023-03-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1232439, encodeId=de1c123243921, content=二审马上一个月了审稿人也没提多少问题啊等到心梗了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89295434420, createdName=ms7000000746658693, createdTime=Thu Jul 14 15:24:20 CST 2022, time=2022-07-14, status=1, ipAttribution=)]

2023-09-08 ms1000000907051820 来自河南省

偏重的研究方向：医学;分子生物学
经验分享：请问under review 后多久有审稿意见回来？被拒稿的概率大吗？投稿小CDD被拒了，转投这个，送审了……担心😓

104 18

展开18条回复

[GetPortalCommentsPageByObjectIdResponse(id=1223591, encodeId=308412235916f, content=偏重的研究方向：生命科学;生命科学医药学 经验分享：这个杂志真的慢生命科学方向的着急一定要慎投投过去了 Manuscript Submitted持续了12天了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9bf5125548, createdName=146453fam52暂无昵称, createdTime=Tue May 31 13:38:07 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230893, encodeId=e1c91230893ca, content=偏重的研究方向：医学;生命科学 经验分享：6.7号送审，under review，一个月了还没消息，医学类一般几个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabc8228192, createdName=ms8000002010566297, createdTime=Wed Jul 06 12:18:42 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154655, encodeId=31112154655d3, content=偏重的研究方向：医学;神经免疫 经验分享：大家最近投这个的进度怎么样呀？我们最近投的一篇2周了还在manuscript submitted，很着急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19c03114550, createdName=Ozeaaan, createdTime=Sat Aug 26 08:39:27 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156715, encodeId=1bc32156e15fd, content=偏重的研究方向：医学;分子生物学 经验分享：请问under review 后多久有审稿意见回来？被拒稿的概率大吗？投稿小CDD被拒了，转投这个，送审了……担心😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Fri Sep 08 15:23:25 CST 2023, time=2023-09-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1221757, encodeId=619e1221e57aa, content=请问一下:Submitted状态5天了，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Mon May 23 14:40:15 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166784, encodeId=54962166e8461, content=偏重的研究方向：神经内分泌;肠道菌群 经验分享：大家都是with editor 多久送审的?我这边with editor一周了，加上之前的submitted，前后加起来已经两周了，等的捉急，着急毕业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb55107687, createdName=悲伤的猪大肠, createdTime=Sun Nov 05 11:37:18 CST 2023, time=2023-11-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2165098, encodeId=5c24216509831, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基础医学 经验分享：第一次投稿15+的综合期刊，期间各种焦虑不安，好在虽然波折但是总体顺利。审稿人都很友好，对于完善文章逻辑、优化结果展示都提出了很多有用的建议，也一一遵照修改了。 贡献一波时间线，再次祝大家投稿顺利，成果多多！ 7-26 Submit 8-15 With Editor 8-16 Under Review 9-13 Major Revision 10-2 Resubmit 10-4 Under Review 10-22 Required Reviews Completed 10-25 Accept with no change, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231105/78c8e721cf4145ccb144631f19378e1f/f8edb1c66f194d06b01e9cc8bb05e117.jpg, createdBy=32d65269159, createdName=Getting accept, createdTime=Thu Oct 26 21:06:03 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息？已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2119953, encodeId=9f66211995360, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：医学基础 经验分享：分享一下投稿经历 11-29 submit 11-26 with editor 11-29 under review 12-21 major review 2-8 re-submit后直接under review 3-10 accept 比较流畅的投稿经历，不过也经历了国自然截止期二审时间长于一审的焦虑，好在最后都赶上了。希望大家都投稿顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f41700843, createdName=1de7ee0bm45(暂无匿称), createdTime=Thu Mar 16 13:33:35 CST 2023, time=2023-03-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1232439, encodeId=de1c123243921, content=二审马上一个月了审稿人也没提多少问题啊等到心梗了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89295434420, createdName=ms7000000746658693, createdTime=Thu Jul 14 15:24:20 CST 2022, time=2022-07-14, status=1, ipAttribution=)]

2022-05-23 1225f99em69(暂无昵称)

请问一下:Submitted状态5天了，正常吗？

96 18

展开18条回复

[GetPortalCommentsPageByObjectIdResponse(id=1223591, encodeId=308412235916f, content=偏重的研究方向：生命科学;生命科学医药学 经验分享：这个杂志真的慢生命科学方向的着急一定要慎投投过去了 Manuscript Submitted持续了12天了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9bf5125548, createdName=146453fam52暂无昵称, createdTime=Tue May 31 13:38:07 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230893, encodeId=e1c91230893ca, content=偏重的研究方向：医学;生命科学 经验分享：6.7号送审，under review，一个月了还没消息，医学类一般几个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabc8228192, createdName=ms8000002010566297, createdTime=Wed Jul 06 12:18:42 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154655, encodeId=31112154655d3, content=偏重的研究方向：医学;神经免疫 经验分享：大家最近投这个的进度怎么样呀？我们最近投的一篇2周了还在manuscript submitted，很着急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19c03114550, createdName=Ozeaaan, createdTime=Sat Aug 26 08:39:27 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156715, encodeId=1bc32156e15fd, content=偏重的研究方向：医学;分子生物学 经验分享：请问under review 后多久有审稿意见回来？被拒稿的概率大吗？投稿小CDD被拒了，转投这个，送审了……担心😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Fri Sep 08 15:23:25 CST 2023, time=2023-09-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1221757, encodeId=619e1221e57aa, content=请问一下:Submitted状态5天了，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Mon May 23 14:40:15 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166784, encodeId=54962166e8461, content=偏重的研究方向：神经内分泌;肠道菌群 经验分享：大家都是with editor 多久送审的?我这边with editor一周了，加上之前的submitted，前后加起来已经两周了，等的捉急，着急毕业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb55107687, createdName=悲伤的猪大肠, createdTime=Sun Nov 05 11:37:18 CST 2023, time=2023-11-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2165098, encodeId=5c24216509831, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基础医学 经验分享：第一次投稿15+的综合期刊，期间各种焦虑不安，好在虽然波折但是总体顺利。审稿人都很友好，对于完善文章逻辑、优化结果展示都提出了很多有用的建议，也一一遵照修改了。 贡献一波时间线，再次祝大家投稿顺利，成果多多！ 7-26 Submit 8-15 With Editor 8-16 Under Review 9-13 Major Revision 10-2 Resubmit 10-4 Under Review 10-22 Required Reviews Completed 10-25 Accept with no change, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231105/78c8e721cf4145ccb144631f19378e1f/f8edb1c66f194d06b01e9cc8bb05e117.jpg, createdBy=32d65269159, createdName=Getting accept, createdTime=Thu Oct 26 21:06:03 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息？已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2119953, encodeId=9f66211995360, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：医学基础 经验分享：分享一下投稿经历 11-29 submit 11-26 with editor 11-29 under review 12-21 major review 2-8 re-submit后直接under review 3-10 accept 比较流畅的投稿经历，不过也经历了国自然截止期二审时间长于一审的焦虑，好在最后都赶上了。希望大家都投稿顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f41700843, createdName=1de7ee0bm45(暂无匿称), createdTime=Thu Mar 16 13:33:35 CST 2023, time=2023-03-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1232439, encodeId=de1c123243921, content=二审马上一个月了审稿人也没提多少问题啊等到心梗了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89295434420, createdName=ms7000000746658693, createdTime=Thu Jul 14 15:24:20 CST 2022, time=2022-07-14, status=1, ipAttribution=)]

2023-11-05 悲伤的猪大肠来自陕西省

偏重的研究方向：神经内分泌;肠道菌群
经验分享：大家都是with editor 多久送审的?我这边with editor一周了，加上之前的submitted，前后加起来已经两周了，等的捉急，着急毕业。

207 17

展开17条回复

[GetPortalCommentsPageByObjectIdResponse(id=1223591, encodeId=308412235916f, content=偏重的研究方向：生命科学;生命科学医药学 经验分享：这个杂志真的慢生命科学方向的着急一定要慎投投过去了 Manuscript Submitted持续了12天了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9bf5125548, createdName=146453fam52暂无昵称, createdTime=Tue May 31 13:38:07 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230893, encodeId=e1c91230893ca, content=偏重的研究方向：医学;生命科学 经验分享：6.7号送审，under review，一个月了还没消息，医学类一般几个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabc8228192, createdName=ms8000002010566297, createdTime=Wed Jul 06 12:18:42 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154655, encodeId=31112154655d3, content=偏重的研究方向：医学;神经免疫 经验分享：大家最近投这个的进度怎么样呀？我们最近投的一篇2周了还在manuscript submitted，很着急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19c03114550, createdName=Ozeaaan, createdTime=Sat Aug 26 08:39:27 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156715, encodeId=1bc32156e15fd, content=偏重的研究方向：医学;分子生物学 经验分享：请问under review 后多久有审稿意见回来？被拒稿的概率大吗？投稿小CDD被拒了，转投这个，送审了……担心😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Fri Sep 08 15:23:25 CST 2023, time=2023-09-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1221757, encodeId=619e1221e57aa, content=请问一下:Submitted状态5天了，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Mon May 23 14:40:15 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166784, encodeId=54962166e8461, content=偏重的研究方向：神经内分泌;肠道菌群 经验分享：大家都是with editor 多久送审的?我这边with editor一周了，加上之前的submitted，前后加起来已经两周了，等的捉急，着急毕业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb55107687, createdName=悲伤的猪大肠, createdTime=Sun Nov 05 11:37:18 CST 2023, time=2023-11-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2165098, encodeId=5c24216509831, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基础医学 经验分享：第一次投稿15+的综合期刊，期间各种焦虑不安，好在虽然波折但是总体顺利。审稿人都很友好，对于完善文章逻辑、优化结果展示都提出了很多有用的建议，也一一遵照修改了。 贡献一波时间线，再次祝大家投稿顺利，成果多多！ 7-26 Submit 8-15 With Editor 8-16 Under Review 9-13 Major Revision 10-2 Resubmit 10-4 Under Review 10-22 Required Reviews Completed 10-25 Accept with no change, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231105/78c8e721cf4145ccb144631f19378e1f/f8edb1c66f194d06b01e9cc8bb05e117.jpg, createdBy=32d65269159, createdName=Getting accept, createdTime=Thu Oct 26 21:06:03 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息？已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2119953, encodeId=9f66211995360, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：医学基础 经验分享：分享一下投稿经历 11-29 submit 11-26 with editor 11-29 under review 12-21 major review 2-8 re-submit后直接under review 3-10 accept 比较流畅的投稿经历，不过也经历了国自然截止期二审时间长于一审的焦虑，好在最后都赶上了。希望大家都投稿顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f41700843, createdName=1de7ee0bm45(暂无匿称), createdTime=Thu Mar 16 13:33:35 CST 2023, time=2023-03-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1232439, encodeId=de1c123243921, content=二审马上一个月了审稿人也没提多少问题啊等到心梗了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89295434420, createdName=ms7000000746658693, createdTime=Thu Jul 14 15:24:20 CST 2022, time=2022-07-14, status=1, ipAttribution=)]

2023-10-26 Getting accept 来自江苏省

审稿速度:2.0 | 投稿命中率:50.0
偏重的研究方向：基础医学
经验分享：第一次投稿15+的综合期刊，期间各种焦虑不安，好在虽然波折但是总体顺利。审稿人都很友好，对于完善文章逻辑、优化结果展示都提出了很多有用的建议，也一一遵照修改了。
贡献一波时间线，再次祝大家投稿顺利，成果多多！
7-26 Submit
8-15 With Editor
8-16 Under Review
9-13 Major Revision
10-2 Resubmit
10-4 Under Review
10-22 Required Reviews Completed
10-25 Accept with no change

134 16

展开16条回复

[GetPortalCommentsPageByObjectIdResponse(id=1223591, encodeId=308412235916f, content=偏重的研究方向：生命科学;生命科学医药学 经验分享：这个杂志真的慢生命科学方向的着急一定要慎投投过去了 Manuscript Submitted持续了12天了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9bf5125548, createdName=146453fam52暂无昵称, createdTime=Tue May 31 13:38:07 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230893, encodeId=e1c91230893ca, content=偏重的研究方向：医学;生命科学 经验分享：6.7号送审，under review，一个月了还没消息，医学类一般几个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabc8228192, createdName=ms8000002010566297, createdTime=Wed Jul 06 12:18:42 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154655, encodeId=31112154655d3, content=偏重的研究方向：医学;神经免疫 经验分享：大家最近投这个的进度怎么样呀？我们最近投的一篇2周了还在manuscript submitted，很着急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19c03114550, createdName=Ozeaaan, createdTime=Sat Aug 26 08:39:27 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156715, encodeId=1bc32156e15fd, content=偏重的研究方向：医学;分子生物学 经验分享：请问under review 后多久有审稿意见回来？被拒稿的概率大吗？投稿小CDD被拒了，转投这个，送审了……担心😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Fri Sep 08 15:23:25 CST 2023, time=2023-09-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1221757, encodeId=619e1221e57aa, content=请问一下:Submitted状态5天了，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Mon May 23 14:40:15 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166784, encodeId=54962166e8461, content=偏重的研究方向：神经内分泌;肠道菌群 经验分享：大家都是with editor 多久送审的?我这边with editor一周了，加上之前的submitted，前后加起来已经两周了，等的捉急，着急毕业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb55107687, createdName=悲伤的猪大肠, createdTime=Sun Nov 05 11:37:18 CST 2023, time=2023-11-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2165098, encodeId=5c24216509831, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基础医学 经验分享：第一次投稿15+的综合期刊，期间各种焦虑不安，好在虽然波折但是总体顺利。审稿人都很友好，对于完善文章逻辑、优化结果展示都提出了很多有用的建议，也一一遵照修改了。 贡献一波时间线，再次祝大家投稿顺利，成果多多！ 7-26 Submit 8-15 With Editor 8-16 Under Review 9-13 Major Revision 10-2 Resubmit 10-4 Under Review 10-22 Required Reviews Completed 10-25 Accept with no change, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231105/78c8e721cf4145ccb144631f19378e1f/f8edb1c66f194d06b01e9cc8bb05e117.jpg, createdBy=32d65269159, createdName=Getting accept, createdTime=Thu Oct 26 21:06:03 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息？已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2119953, encodeId=9f66211995360, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：医学基础 经验分享：分享一下投稿经历 11-29 submit 11-26 with editor 11-29 under review 12-21 major review 2-8 re-submit后直接under review 3-10 accept 比较流畅的投稿经历，不过也经历了国自然截止期二审时间长于一审的焦虑，好在最后都赶上了。希望大家都投稿顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f41700843, createdName=1de7ee0bm45(暂无匿称), createdTime=Thu Mar 16 13:33:35 CST 2023, time=2023-03-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1232439, encodeId=de1c123243921, content=二审马上一个月了审稿人也没提多少问题啊等到心梗了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89295434420, createdName=ms7000000746658693, createdTime=Thu Jul 14 15:24:20 CST 2022, time=2022-07-14, status=1, ipAttribution=)]

2024-01-23 1522336 来自重庆

请问with editor大概多久能有消息？已经一周多了

151 15

展开15条回复

[GetPortalCommentsPageByObjectIdResponse(id=1223591, encodeId=308412235916f, content=偏重的研究方向：生命科学;生命科学医药学 经验分享：这个杂志真的慢生命科学方向的着急一定要慎投投过去了 Manuscript Submitted持续了12天了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9bf5125548, createdName=146453fam52暂无昵称, createdTime=Tue May 31 13:38:07 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230893, encodeId=e1c91230893ca, content=偏重的研究方向：医学;生命科学 经验分享：6.7号送审，under review，一个月了还没消息，医学类一般几个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabc8228192, createdName=ms8000002010566297, createdTime=Wed Jul 06 12:18:42 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154655, encodeId=31112154655d3, content=偏重的研究方向：医学;神经免疫 经验分享：大家最近投这个的进度怎么样呀？我们最近投的一篇2周了还在manuscript submitted，很着急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19c03114550, createdName=Ozeaaan, createdTime=Sat Aug 26 08:39:27 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156715, encodeId=1bc32156e15fd, content=偏重的研究方向：医学;分子生物学 经验分享：请问under review 后多久有审稿意见回来？被拒稿的概率大吗？投稿小CDD被拒了，转投这个，送审了……担心😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Fri Sep 08 15:23:25 CST 2023, time=2023-09-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1221757, encodeId=619e1221e57aa, content=请问一下:Submitted状态5天了，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Mon May 23 14:40:15 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166784, encodeId=54962166e8461, content=偏重的研究方向：神经内分泌;肠道菌群 经验分享：大家都是with editor 多久送审的?我这边with editor一周了，加上之前的submitted，前后加起来已经两周了，等的捉急，着急毕业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb55107687, createdName=悲伤的猪大肠, createdTime=Sun Nov 05 11:37:18 CST 2023, time=2023-11-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2165098, encodeId=5c24216509831, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基础医学 经验分享：第一次投稿15+的综合期刊，期间各种焦虑不安，好在虽然波折但是总体顺利。审稿人都很友好，对于完善文章逻辑、优化结果展示都提出了很多有用的建议，也一一遵照修改了。 贡献一波时间线，再次祝大家投稿顺利，成果多多！ 7-26 Submit 8-15 With Editor 8-16 Under Review 9-13 Major Revision 10-2 Resubmit 10-4 Under Review 10-22 Required Reviews Completed 10-25 Accept with no change, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231105/78c8e721cf4145ccb144631f19378e1f/f8edb1c66f194d06b01e9cc8bb05e117.jpg, createdBy=32d65269159, createdName=Getting accept, createdTime=Thu Oct 26 21:06:03 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息？已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2119953, encodeId=9f66211995360, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：医学基础 经验分享：分享一下投稿经历 11-29 submit 11-26 with editor 11-29 under review 12-21 major review 2-8 re-submit后直接under review 3-10 accept 比较流畅的投稿经历，不过也经历了国自然截止期二审时间长于一审的焦虑，好在最后都赶上了。希望大家都投稿顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f41700843, createdName=1de7ee0bm45(暂无匿称), createdTime=Thu Mar 16 13:33:35 CST 2023, time=2023-03-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1232439, encodeId=de1c123243921, content=二审马上一个月了审稿人也没提多少问题啊等到心梗了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89295434420, createdName=ms7000000746658693, createdTime=Thu Jul 14 15:24:20 CST 2022, time=2022-07-14, status=1, ipAttribution=)]

2023-03-16 1de7ee0bm45(暂无匿称) 来自广东省

审稿速度:1.0 | 投稿命中率:25.0
偏重的研究方向：医学基础
经验分享：分享一下投稿经历
11-29 submit
11-26 with editor
11-29 under review
12-21 major review
2-8 re-submit后直接under review
3-10 accept
比较流畅的投稿经历，不过也经历了国自然截止期二审时间长于一审的焦虑，好在最后都赶上了。希望大家都投稿顺利

105 14

展开14条回复

[GetPortalCommentsPageByObjectIdResponse(id=1223591, encodeId=308412235916f, content=偏重的研究方向：生命科学;生命科学医药学 经验分享：这个杂志真的慢生命科学方向的着急一定要慎投投过去了 Manuscript Submitted持续了12天了还没有消息, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=103, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=f9bf5125548, createdName=146453fam52暂无昵称, createdTime=Tue May 31 13:38:07 CST 2022, time=2022-05-31, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=1230893, encodeId=e1c91230893ca, content=偏重的研究方向：医学;生命科学 经验分享：6.7号送审，under review，一个月了还没消息，医学类一般几个审稿人？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=79, replyNumber=23, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=fabc8228192, createdName=ms8000002010566297, createdTime=Wed Jul 06 12:18:42 CST 2022, time=2022-07-06, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2154655, encodeId=31112154655d3, content=偏重的研究方向：医学;神经免疫 经验分享：大家最近投这个的进度怎么样呀？我们最近投的一篇2周了还在manuscript submitted，很着急。。。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=247, replyNumber=19, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=19c03114550, createdName=Ozeaaan, createdTime=Sat Aug 26 08:39:27 CST 2023, time=2023-08-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2156715, encodeId=1bc32156e15fd, content=偏重的研究方向：医学;分子生物学 经验分享：请问under review 后多久有审稿意见回来？被拒稿的概率大吗？投稿小CDD被拒了，转投这个，送审了……担心😓, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=104, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=98915615415, createdName=ms1000000907051820, createdTime=Fri Sep 08 15:23:25 CST 2023, time=2023-09-08, status=1, ipAttribution=河南省), GetPortalCommentsPageByObjectIdResponse(id=1221757, encodeId=619e1221e57aa, content=请问一下:Submitted状态5天了，正常吗？, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=96, replyNumber=18, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=07092326647, createdName=1225f99em69(暂无昵称), createdTime=Mon May 23 14:40:15 CST 2022, time=2022-05-23, status=1, ipAttribution=), GetPortalCommentsPageByObjectIdResponse(id=2166784, encodeId=54962166e8461, content=偏重的研究方向：神经内分泌;肠道菌群 经验分享：大家都是with editor 多久送审的?我这边with editor一周了，加上之前的submitted，前后加起来已经两周了，等的捉急，着急毕业。, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=207, replyNumber=17, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=5cb55107687, createdName=悲伤的猪大肠, createdTime=Sun Nov 05 11:37:18 CST 2023, time=2023-11-05, status=1, ipAttribution=陕西省), GetPortalCommentsPageByObjectIdResponse(id=2165098, encodeId=5c24216509831, content=审稿速度:2.0 | 投稿命中率:50.0 偏重的研究方向：基础医学 经验分享：第一次投稿15+的综合期刊，期间各种焦虑不安，好在虽然波折但是总体顺利。审稿人都很友好，对于完善文章逻辑、优化结果展示都提出了很多有用的建议，也一一遵照修改了。 贡献一波时间线，再次祝大家投稿顺利，成果多多！ 7-26 Submit 8-15 With Editor 8-16 Under Review 9-13 Major Revision 10-2 Resubmit 10-4 Under Review 10-22 Required Reviews Completed 10-25 Accept with no change, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=134, replyNumber=16, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=https://img.medsci.cn/20231105/78c8e721cf4145ccb144631f19378e1f/f8edb1c66f194d06b01e9cc8bb05e117.jpg, createdBy=32d65269159, createdName=Getting accept, createdTime=Thu Oct 26 21:06:03 CST 2023, time=2023-10-26, status=1, ipAttribution=江苏省), GetPortalCommentsPageByObjectIdResponse(id=2183499, encodeId=e8ff218349976, content=请问with editor大概多久能有消息？已经一周多了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=151, replyNumber=15, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=80b31945016, createdName=1522336, createdTime=Tue Jan 23 20:37:57 CST 2024, time=2024-01-23, status=1, ipAttribution=重庆), GetPortalCommentsPageByObjectIdResponse(id=2119953, encodeId=9f66211995360, content=审稿速度:1.0 | 投稿命中率:25.0 偏重的研究方向：医学基础 经验分享：分享一下投稿经历 11-29 submit 11-26 with editor 11-29 under review 12-21 major review 2-8 re-submit后直接under review 3-10 accept 比较流畅的投稿经历，不过也经历了国自然截止期二审时间长于一审的焦虑，好在最后都赶上了。希望大家都投稿顺利, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=105, replyNumber=14, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=, createdBy=05f41700843, createdName=1de7ee0bm45(暂无匿称), createdTime=Thu Mar 16 13:33:35 CST 2023, time=2023-03-16, status=1, ipAttribution=广东省), GetPortalCommentsPageByObjectIdResponse(id=1232439, encodeId=de1c123243921, content=二审马上一个月了审稿人也没提多少问题啊等到心梗了, beContent=null, objectType=tool_impact_factor, channel=null, level=null, likeNumber=71, replyNumber=13, topicName=null, topicId=null, topicList=[], attachment=null, authenticateStatus=null, createdAvatar=null, createdBy=89295434420, createdName=ms7000000746658693, createdTime=Thu Jul 14 15:24:20 CST 2022, time=2022-07-14, status=1, ipAttribution=)]

2022-07-14 ms7000000746658693

二审马上一个月了审稿人也没提多少问题啊等到心梗了

71 13

展开13条回复

内科

外科

专科科室

热点

按科室浏览

临床工具

科研工具

其他工具

科研数智化

真实世界研究解决方案

数字化学术传播解决方案

其它

期刊讨论

科室

工具

服务